Basel, Basel-Stadt, Switzerland The leading representative office of defined VC is situated in the Basel. The fund was located in Europe if to be more exact in Switzerland.
Among the most successful fund investment fields, there are Innovation Management, Professional Services. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Renovis
The usual cause for the fund is to invest in rounds with 9 partakers. The meaningful sponsors for the fund in investment in the same round are Yasuda Enterprise Development, Venrock, Skyline Ventures. In the next rounds fund is usually obtained by MDS Capital, Invus, HealthCap.
The higher amount of exits for fund were in 2019. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2002.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Anchor Group | Geneva, Geneve, Switzerland |
| Glastad Invest | Farsund, Norway, Vest-Agder |
| Hongcheng Dasha | China, Guangdong, Jiangxi |
| Nippon Electric Glass | Japan, Otsu, Shiga Prefecture |
| Ourpalm | Beijing, Beijing, China |
| Robert H. Lessin Venture Capital | New York, New York, United States |
| SYNNEX | California, Fremont, United States |
| The Danone.Communities Mutual Fund | - |
| YinHan | China, Guangdong, Guangzhou |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Renovis | $34M | 10 Jan 2002 | South San Francisco, California, United States | ||
Cytokinetics, Inc. | $20M | 12 Oct 1999 | South San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Renovis | $34M | 10 Jan 2002 | South San Francisco, California, United States | ||
Cytokinetics, Inc. | $20M | 12 Oct 1999 | South San Francisco, California, United States |
